Is serum B7-H4 expression a significant prognostic indicator for patients with gastric cancer?
sB7-H4 is a valuable blood marker for predicting the progression and prognosis of patients with gastric cancer.
These data suggest that upregulation of FasL by LPA provides EOC immune-privilege and leads to apoptosis of activated T lymphocytes.